Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing-Reference-Cited by-同舟云学术

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing

Published:2010-10 Issue:4 Volume:53 Page:616-623
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Cheng Wendy S.C.,Roberts Stuart K.,McCaughan Geoffrey,Sievert William,Weltman Martin,Crawford Darrell,Rawlinson William,Marks Philippa S.,Thommes James,Rizkalla Bishoy,Yoshihara Motoko,Dore Gregory J

Publisher

Elsevier BV

Subject

Hepatology

Reference32 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis;Marrache;J Viral Hepat,2005

5. Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b;Abergel;J Viral Hepat,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection;Egyptian Liver Journal;2023-06-28

2. Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients;Expert Review of Gastroenterology & Hepatology;2019-08-16

3. Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study;Hepatology Research;2018-11-13

4. Regulation of interferon signaling and HCV‑RNA replication by extracellular matrix;International Journal of Molecular Medicine;2018-05-18

5. Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based “Triple Therapy” Experience in Southern Italy;Reviews on Recent Clinical Trials;2016-10-04